Nitroprussid-Natrium Aftpharm (Sodium Nitroprusside)

Sodium nitroprusside, the active ingredient in Nitroprussid-Natrium Aftpharm, is a vasodilator presented as an intravenous solution for intravenous use. It releases nitric oxide to relax arterial and venous smooth muscle, providing rapid blood pressure reduction in hypertensive emergencies, facilitating controlled hypotension during surgery, and supporting management of acute heart failure.

GNH USA supplies Nitroprussid-Natrium Aftpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for bulk manufacturing, quality assurance, and regulatory support across EU and global markets.

Sodium nitroprusside is employed in acute cardiovascular conditions where rapid and precise blood pressure control is required.

- Hypertensive emergencies: rapidly lowers severe elevations in blood pressure to prevent end‑organ damage. - Controlled hypotension during surgery: enables titrated reduction of arterial pressure to minimize intra‑operative bleeding. - Acute heart failure: decreases preload and afterload, improving cardiac output in critical care settings.

Sodium nitroprusside may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: transient throbbing pain due to rapid vasodilation. - Nausea: mild gastrointestinal upset. - Flushing: sensation of warmth and skin reddening. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Cyanide toxicity: accumulation leading to metabolic acidosis and neurologic signs. - Methemoglobinemia: impaired oxygen delivery due to oxidized hemoglobin. - Severe hypotension: excessive blood pressure drop causing organ hypoperfusion. - Allergic reaction: rash, itching, or anaphylaxis in susceptible individuals.

When using sodium nitroprusside, careful monitoring and specific precautions are essential to ensure safety.

- Monitor blood pressure: adjust infusion rate continuously to avoid excessive hypotension. - Assess cyanide levels: especially during prolonged infusions or high-dose therapy. - Use caution in renal or hepatic impairment: reduced clearance may increase risk of toxicity. - Avoid concurrent potent vasodilators: additive effects can cause profound hypotension. - Pregnancy and lactation: safety not established; use only if potential benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium nitroprusside can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other nitric oxide donors (e.g., nitroglycerin): additive vasodilation may cause severe hypotension. - Potent vasodilators (e.g., hydralazine): combined effect can lead to uncontrolled blood pressure fall.

Moderate Interactions (Monitor Closely): - Loop diuretics: may enhance hypotensive response. - Beta‑blockers: may mask tachycardia that signals excessive hypotension. - ACE inhibitors or ARBs: additive blood pressure‑lowering effect requires dose adjustment.